Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points. 1985

V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova

Recombinants with a centrally located crossover point were selected from crosses between poliovirus type 1 strains and intertypic (type 3/type 1) recombinants. Two such recombinants were characterized in some detail. In one of them (v1/a1-6), the 5' half of the genome was derived from a virulent type 1 strain, while the 3' half came from an attenuated type 1 strain. The genome of the other recombinant (a1/v1-7) had the reverse organization, with the 5' and 3' halves being derived from the type 1 attenuated and virulent strains, respectively. As deduced from the RNase T1 oligonucleotide maps, the a1/v1-7 genome also had a relatively short centrally located insert of the poliovirus type 3 origin. Both recombinants exhibited ts phenotypes. The RNA phenotypes of the recombinants corresponded to that of the parent donating the 3' half of the genome, v1/a1-6 and a1/v1-7 expressing RNA- and RNA +/- characters, respectively. Despite being a ts RNA- virus, v1/a1-6 proved to be neurovirulent when injected intracerebrally into Cercopithecus aethiops monkeys, although it exhibited a somewhat diminished level of pathogenicity as compared to its virulent type 1 parent. Recombinant a1/v1-7 behaved as an attenuated strain. These data supported our previous conclusion drawn from the experiments with intertypic poliovirus recombinants that the attenuated phenotype of poliovirus depends largely on the structure of the 5' half of its genome, although mutations of the 3' half may alleviate the virulence of the virus to a degree.

UI MeSH Term Description Entries
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D003434 Crossing Over, Genetic The reciprocal exchange of segments at corresponding positions along pairs of homologous CHROMOSOMES by symmetrical breakage and crosswise rejoining forming cross-over sites (HOLLIDAY JUNCTIONS) that are resolved during CHROMOSOME SEGREGATION. Crossing-over typically occurs during MEIOSIS but it may also occur in the absence of meiosis, for example, with bacterial chromosomes, organelle chromosomes, or somatic cell nuclear chromosomes. Crossing Over,Crossing-Over, Genetic,Crossing Overs,Genetic Crossing Over,Genetic Crossing-Over
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006163 Ribonuclease T1 An enzyme catalyzing the endonucleolytic cleavage of RNA at the 3'-position of a guanylate residue. EC 3.1.27.3. Guanyloribonuclease,RNase T1,Ribonuclease N1,Aspergillus oryzae Ribonuclease,Guanyl-Specific RNase,RNase Apl,RNase F1,RNase Pch 1,RNase ST,Ribonuclease F1,Ribonuclease F2,Ribonuclease ST,Ribonuclease T-1,T 1 RNase,Guanyl Specific RNase,RNase, Guanyl-Specific,RNase, T 1,Ribonuclease T 1,Ribonuclease, Aspergillus oryzae
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity

Related Publications

V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
February 1987, Journal of virology,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
January 1964, Journal of hygiene, epidemiology, microbiology, and immunology,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
June 2002, Journal of virology,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
January 1961, Acta medica Iugoslavica,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
January 1974, Bulletin of the World Health Organization,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
October 1988, Journal of virology,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
January 1973, Archiv fur die gesamte Virusforschung,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
May 1978, Archives internationales de physiologie et de biochimie,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
December 1985, Virology,
V I Agol, and S G Drozdov, and V P Grachev, and M S Kolesnikova, and V G Kozlov, and N M Ralph, and L I Romanova, and E A Tolskaya, and A V Tyufanov, and E G Viktorova
May 1960, Virology,
Copied contents to your clipboard!